Updates in Treatment Strategies for Advanced Biliary Tract Cancer

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss advances in treatment options in advanced biliary tract cancer.

EP. 1: Prognosis and Standards of Care in Advanced Biliary Tract Cancer

May 29th 2024

Milind Javle, MD, and Rachna Shroff, MD, MS, FASCO, and a patient discuss prognosis and standard-of-care treatment for patients with advanced biliary tract cancer.

EP. 2: Discussion of a Patient Case of Advanced BTC

May 29th 2024

Milind Javle, MD, and Rachna Shroff, MD, MS, FASCO, discuss a case of advanced biliary tract cancer with a patient.

EP. 3: Homing in on the TOPAZ-1 Trial in Biliary Tract Cancer

May 29th 2024

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss the phase 3 TOPAZ-1 trial in advanced biliary tract cancer.

EP. 4: Putting TOPAZ-1 Data into Context for Patients With Advanced BTC

May 29th 2024

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient put the TOPAZ-1 data into context for patients with advanced biliary tract cancer.

EP. 5: Clinical Implications of 3-Year OS Data With Durvalumab/Chemo in Advanced BTC

May 29th 2024

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss the clinical implications of 3-year survival data from TOPAZ-1 in advanced biliary tract cancer.

EP. 6: Considering Factors When Choosing Among IO Agents in Advanced BTC

May 30th 2024

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss considering factors for immunotherapy agents in advanced biliary tract cancer.

EP. 7: Factoring in Trastuzumab Deruxtecan in the Advanced BTC Setting

May 30th 2024

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss how to factor in trastuzumab deruxtecan in advanced biliary tract cancer.

EP. 8: The Investigational Pipeline for Advanced BTC

May 30th 2024

Milind Javle, MD; Rachna Shroff, MD, MS, FASCO; and a patient discuss ongoing research efforts in advanced biliary tract cancer.